Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 264,158 shares at $282.43 ($74.3M) on 2022-07-25, disclosed to the SEC on 2022-07-27.
Open-market sale of $74.3M VRTX by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $279.44 | 13,869 | $3.9M | 5.2% |
| 2 | $279.44 | 13,869 | $3.9M | 5.2% |
| 3 | $280.37 | 32,983 | $9.2M | 12.4% |
| 4 | $280.37 | 32,983 | $9.2M | 12.4% |
| 5 | $281.27 | 34,090 | $9.6M | 12.9% |
| 6 | $281.27 | 34,090 |
| $9.6M |
| 12.9% |
| 7 | $282.43 | 40,666 | $11.5M | 15.5% |
| 8 | $282.43 | 40,666 | $11.5M | 15.5% |
| 9 | $283.42 | 10,471 | $3.0M | 4.0% |
| 10 | $283.42 | 10,471 | $3.0M | 4.0% |
| Total | $281.38 avg | 264,158 | $74.3M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |